Related Experiment Videos
Advances in hematopoietic stem cell culture
J Audet1, P W Zandstra, C J Eaves
1Biotechnology Laboratory, University of British Columbia, Vancouver, Canada.
Current Opinion in Biotechnology
|May 20, 1998
Summary
Advances in hematopoietic stem cell research enable new bioprocess technologies. Understanding cell-specific cytokine needs optimizes hematopoietic cell amplification and culture productivity.
Area of Science:
- Hematology
- Biotechnology
- Cell Biology
Background:
- Recent progress in understanding early hematopoietic cell differentiation.
- Availability of sensitive assays for quantifying hematopoietic stem cells (HSCs) with long-term in vivo repopulating activity.
- Development of recombinant DNA and combinatorial chemistry for producing ligands to enhance cell cultures.
Purpose of the Study:
- To outline the development of robust bioprocess technology for hematopoietic cells.
- To highlight the impact of new reagents and analytical methods on optimizing hematopoietic cell cultures.
- To discuss the complexity introduced by cell-type-specific parameters in bioprocess design.
Main Methods:
- Utilizing sensitive and specific assays to measure HSC frequency.
- Employing recombinant DNA and combinatorial chemistry for ligand production.
- Conducting multifactorial and dose-response analyses to determine optimal culture conditions.
Main Results:
- Identification of specific factors and concentrations for amplifying primitive hematopoietic cell subpopulations.
- Discovery that cytokine depletion rates are cell-type dependent.
- New insights into optimizing the rate and extent of hematopoietic cell amplification.
Conclusions:
- Established assays and reagents facilitate the development of hematopoietic bioprocess technology.
- Cell-type-specific cytokine parameters add complexity to bioprocess system design.
- Optimized bioprocessing requires a nuanced understanding of cellular interactions and factor dynamics.